Speech and music are two fundamentally human activities that are decoded in different brain hemispheres. A new study used a unique approach to reveal why this specialization exists.
Researchers trained machine learning algorithms on data from more than 62,000 patients with a meningioma. Their goal was to find statistical associations between malignancy, survival, and a series of basic clinical variables including tumour size, tumour location, and surgical procedure.
Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient’s progression is different. A new study shows artificial intelligence (AI) analysis of blood samples can predict and explain disease progression, which could one day help doctors choose more appropriate and effective treatments for patients.
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs. But obesity is also a complex condition that cannot be fully explained by the addiction model.
New research shows that machine learning algorithms can accurately assess the capabilities of neurosurgeons during virtual surgery, demonstrating that virtual reality simulators using artificial intelligence can be powerful tools in surgeon training.
Since being diagnosed with Parkinson’s disease (PD) six years ago at the age of 29, Ben Stecher has learned a lot about not just PD, but medical science in general. He has become a patient advocate in a field where the complexity of the science often shuts out anyone who doesn’t have a PhD.
Neuroscientist Gary Armstrong is helping solve one of the mysteries that have made amyotrophic lateral sclerosis (ALS) such a challenging subject of research and treatment.
A team led by Dr. Rolando Del Maestro is playing a major role in perfecting an advanced neurosurgical simulator.
L’Institut et hôpital neurologiques de Montréal (le Neuro) dirigera un partenariat en science ouverte en vue de la mise au point de médicaments de précision indiqués dans la sclérose latérale amyotrophique (SLA) et la maladie de Parkinson (MP).
The Neuro (Montreal Neurological Institute and Hospital) will lead an open science partnership to develop precision drugs for amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD).
Surgery is the only way to stop seizures in 30 per cent of patients with focal drug-resistant epilepsy. A new study finds that inducing seizures before surgery may be a convenient and cost-effective way to determine the brain region where seizures are coming from.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right